These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32987729)

  • 41. Changes in Transcranial Doppler Flow Velocities in Children with Sickle Cell Disease: The Impact of Hydroxyurea Therapy.
    Adegoke SA; Macedo-Campos RS; Braga JAP; Figueiredo MS; Silva GS
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):425-431. PubMed ID: 29056404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. P-Selectin coated microtube for enrichment of CD34+ hematopoietic stem and progenitor cells from human bone marrow.
    Narasipura SD; Wojciechowski JC; Charles N; Liesveld JL; King MR
    Clin Chem; 2008 Jan; 54(1):77-85. PubMed ID: 18024531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hematopoietic defects in mice lacking the sialomucin CD34.
    Cheng J; Baumhueter S; Cacalano G; Carver-Moore K; Thibodeaux H; Thomas R; Broxmeyer HE; Cooper S; Hague N; Moore M; Lasky LA
    Blood; 1996 Jan; 87(2):479-90. PubMed ID: 8555469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Almeida CB; Souza LE; Leonardo FC; Costa FT; Werneck CC; Covas DT; Costa FF; Conran N
    Blood; 2015 Aug; 126(6):711-20. PubMed ID: 26019278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early severe impairment of hematopoietic stem and progenitor cells from the bone marrow caused by CLP sepsis and endotoxemia in a humanized mice model.
    Skirecki T; Kawiak J; Machaj E; Pojda Z; Wasilewska D; Czubak J; Hoser G
    Stem Cell Res Ther; 2015 Aug; 6(1):142. PubMed ID: 26272069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancy.
    Thomas R; Dulman R; Lewis A; Notarangelo B; Yang E
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27816. PubMed ID: 31157521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders.
    Gorur V; Kranc KR; Ganuza M; Telfer P
    Blood Rev; 2024 Jan; 63():101137. PubMed ID: 37919142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.
    Baliga BS; Pace BS; Chen HH; Shah AK; Yang YM
    Am J Hematol; 2000 Nov; 65(3):227-33. PubMed ID: 11074540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes?
    Creary SE; Chisolm DJ; Koch TL; Zigmont VA; Lu B; O'Brien SH
    Pediatr Blood Cancer; 2016 May; 63(5):844-7. PubMed ID: 26797936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea.
    Cartron JP; Elion J
    Transfus Clin Biol; 2008; 15(1-2):39-50. PubMed ID: 18515167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of merocyanine 540 for the isolation of quiescent, primitive human bone marrow hematopoietic progenitor cells.
    Pyatt RE; Jenski LL; Allen R; Cornetta K; Abonour R; Traycoff CM; Srour EF
    J Hematother; 1999 Apr; 8(2):189-98. PubMed ID: 10349913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease.
    Kratovil T; Bulas D; Driscoll MC; Speller-Brown B; McCarter R; Minniti CP
    Pediatr Blood Cancer; 2006 Dec; 47(7):894-900. PubMed ID: 16526051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
    Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
    Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Hydroxyurea on Anthropometry and Serum 25-Hydroxyvitamin D Among Children With Sickle Cell Disease.
    Adegoke SA; Braga JAP; D Adekile A; Figueiredo MS
    J Pediatr Hematol Oncol; 2018 May; 40(4):e243-e247. PubMed ID: 29176461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.